Actively Recruiting

Early Phase 1
Age: 50Years +
All Genders
NCT06066710

Propranolol in Primary Progressive Aphasia

Led by University of Missouri-Columbia · Updated on 2025-03-28

30

Participants Needed

1

Research Sites

150 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The purpose of this study is to find out how the language of people with Primary Progressive Aphasia is affected by Propranolol. Propranolol is not FDA approved for the treatment of Primary Progressive Aphasia. Propranolol is FDA approved for the treatment of heart conditions such as blood pressure. This research is being done because there are currently no drug treatment options for language impairments and anxiety often experienced by people with Primary Progressive Aphasia.

CONDITIONS

Official Title

Propranolol in Primary Progressive Aphasia

Who Can Participate

Age: 50Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 50 and older
  • Diagnosis of Primary Progressive Aphasia
  • Native English speaker
Not Eligible

You will not qualify if you...

  • Unable to provide consent
  • Taking alpha 2 agonists (clonidine and guanfacine)
  • Other major psychological or neurological diagnoses
  • Major head trauma contributing to the condition
  • Allergic reaction to adhesives
  • Uncorrected vision or hearing impairments
  • Diabetes
  • Reactive airway disease
  • Untreated hypothyroidism
  • Bradyarrhythmia
  • Unexplained syncope
  • Pregnancy (assessed verbally on MRI days)
  • Use of drugs interacting with propranolol, such as alpha 2 agonists
  • Claustrophobia or contraindications to MRI including inner ear implants, aneurysm or surgical clips, metal in eye, pacemaker, or unverified implanted devices

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

University of Missouri-Columbia

Columbia, Missouri, United States, 65212

Actively Recruiting

Loading map...

Research Team

D

David Beversdorf, MD

CONTACT

J

Jessica Call

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

QUADRUPLE

Allocation

RANDOMIZED

Model

CROSSOVER

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here